Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor Alexander D Barrow 1 , Melissa A Edeling 1 , Vladimir Trifonov 2 , Jingqin Luo 3 , Piyush Goyal 2 , Benjamin Bohl 2 , Jennifer K Bando 1 , Albert H Kim 4 , John Walker 2 , Mary Andahazy 2 , Mattia Bugatti 5 , Laura Melocchi 5 , William Vermi 6 , Daved H Fremont 1 , Sarah Cox 2 , Marina Cella 1 , Christian Schmedt 2 , Marco Colonna Cell
172(3)
534-548
2018
Zobrazit abstrakt
Many tumors produce platelet-derived growth factor (PDGF)-DD, which promotes cellular proliferation, epithelial-mesenchymal transition, stromal reaction, and angiogenesis through autocrine and paracrine PDGFRβ signaling. By screening a secretome library, we found that the human immunoreceptor NKp44, encoded by NCR2 and expressed on natural killer (NK) cells and innate lymphoid cells, recognizes PDGF-DD. PDGF-DD engagement of NKp44 triggered NK cell secretion of interferon gamma (IFN)-γ and tumor necrosis factor alpha (TNF-α) that induced tumor cell growth arrest. A distinctive transcriptional signature of PDGF-DD-induced cytokines and the downregulation of tumor cell-cycle genes correlated with NCR2 expression and greater survival in glioblastoma. NKp44 expression in mouse NK cells controlled the dissemination of tumors expressing PDGF-DD more effectively than control mice, an effect enhanced by blockade of the inhibitory receptor CD96 or CpG-oligonucleotide treatment. Thus, while cancer cell production of PDGF-DD supports tumor growth and stromal reaction, it concomitantly activates innate immune responses to tumor expansion. | 29275861
|